Get the Stockscreener App
19.96
4.95%
-1.04
After Hours:
20.06
0.10
+0.50%
Biodesix Inc stock is traded at $19.96, with a volume of 64,561.
It is down -4.95% in the last 24 hours and up +30.20% over the past month.
Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.
See More
Previous Close:
$21.00
Open:
$20.73
24h Volume:
64,561
Relative Volume:
0.87
Market Cap:
$206.70M
Revenue:
$88.50M
Net Income/Loss:
$-35.27M
P/E Ratio:
-6.0569
EPS:
-3.2954
Net Cash Flow:
$-23.70M
1W Performance:
-9.89%
1M Performance:
+30.20%
6M Performance:
+153.30%
1Y Performance:
+225.61%
1-Day Range:
$19.56
$21.20
1-Week Range:
$19.56
$23.32
52-Week Range:
$5.26
$24.92
Biodesix Inc Stock (BDSX) Company Profile
Name
Biodesix Inc
Sector
Industry
Phone
303-417-0500
Address
919 WEST DILLON ROAD, LOUISVILLE
Compare BDSX vs TMO, DHR, IDXX, NTRA, A
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BDSX
Biodesix Inc
|
19.96 | 217.47M | 88.50M | -35.27M | -23.70M | -3.2954 |
TMO
Thermo Fisher Scientific Inc
|
543.19 | 198.93B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
205.01 | 142.11B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
576.07 | 43.94B | 4.45B | 1.10B | 1.06B | 13.59 |
NTRA
Natera Inc
|
269.83 | 39.72B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
136.10 | 38.05B | 7.23B | 1.41B | 1.09B | 4.979 |
Biodesix Inc Stock (BDSX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-27-26 | Upgrade | William Blair | Mkt Perform → Outperform |
| May-14-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Sep-16-24 | Initiated | Scotiabank | Sector Outperform |
| Jul-26-24 | Initiated | Craig Hallum | Buy |
| May-13-24 | Initiated | TD Cowen | Buy |
| May-03-24 | Initiated | Lake Street | Buy |
| Nov-17-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-23-20 | Initiated | BTIG Research | Buy |
| Nov-23-20 | Initiated | Canaccord Genuity | Buy |
| Nov-23-20 | Initiated | Morgan Stanley | Overweight |
| Nov-23-20 | Initiated | William Blair | Outperform |
View All
Biodesix Inc Stock (BDSX) Latest News
Biodesix Inc. (BDSX) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Wall Street Analysts Believe Biodesix (BDSX) Could Rally 104.29%: Here's is How to Trade - MSN
AIGH Capital Management LLC Buys Shares of 758,328 Biodesix, Inc. $BDSX - MarketBeat
Biodesix Inc. (BDSX) Edges Lower Amid Consolidation Near ResistanceMFI Overbought - dars.gov.et
Biodesix (BDSX) chair converts 1,361 RSUs and updates holdings - Stock Titan
Biodesix, Inc.(NasdaqGM: BDSX) added to Russell Microcap Value Benchmark Index - marketscreener.com
Biodesix, Inc.(NasdaqGM: BDSX) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Biodesix, Inc.(NasdaqGM: BDSX) added to Russell 3000E Growth Benchmark - marketscreener.com
Biodesix, Inc.(NasdaqGM: BDSX) added to Russell Microcap Index - marketscreener.com
Biodesix, Inc.(NasdaqGM: BDSX) added to Russell 3000E Value Benchmark - marketscreener.com
Biodesix, Inc.(NasdaqGM: BDSX) added to Russell 3000E Index - marketscreener.com
Enterprise value to revenue forward of Biodesix, Inc. – NASDAQ:BDSX - TradingView
Price to earnings forward of Biodesix, Inc. – NASDAQ:BDSX - TradingView
Price to book forward of Biodesix, Inc. – NASDAQ:BDSX - TradingView
Biodesix, Inc. Actuals & Estimates (NASDAQ:BDSX) - TradingView
Biodesix (BDSX) Stock Gets Fair Value Bump As Analysts Back Growth Path - Yahoo Finance
Biodesix, Inc. Actuals & Estimates (BOATS:BDSX) - TradingView
BDSX Forecast — Price Target — Prediction for 2027 - TradingView
BDSX Initiated Coverage by Roth Capital -- Price Target Set at $32 - GuruFocus
Roth Capital Initiates Biodesix at Buy With $32 Price Target - marketscreener.com
Biodesix (BDSX) Coverage Initiated with Positive Outlook - GuruFocus
Biodesix | SCHEDULE 13G/A: Others - Moomoo
Biodesix Inc (BDSX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Biodesix (BDSX) Surges 10.43%: Key Levels and What Lies AheadLow Volume Node - dars.gov.et
Biodesix (BDSX) surges 10.5%: Is this an indication of further gains? - MSN
Biodesix Inc. (BDSX) Surges Over 10%: Key Levels to Watch After the BreakoutETF Inflow Streak - DonanımHaber
Are medical stocks lagging Biodesix (BDSX) this year? - MSN
Biodesix (BDSX) Surges 10.5%: Is This an Indication of Further Gains? - Yahoo Finance
BDSX News | BIODESIX INC (NASDAQ:BDSX) - ChartMill
Soleus discloses 525,241-share (5.1%) stake in Biodesix (BDSX) - Stock Titan
Canaccord raises Biodesix stock price target to $27 on growth outlook By Investing.com - Investing.com Australia
Canaccord raises Biodesix stock price target to $27 on growth outlook - Investing.com UK
Biodesix Inc (BDSX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Biodesix Inc (BDSX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Biodesix Inc (BDSX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Biodesix Inc (BDSX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Biodesix Inc (BDSX) Institutional Confidence - TradingKey
BDSX Technical Analysis & Stock Price Forecast - Intellectia AI
Biodesix Inc (BDSX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Biodesix Inc (BDSX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Biodesix Inc (BDSX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
BDSX Initiates Coverage On HC Wainwright & Co. -- Rating Set to Buy - GuruFocus
Are Medical Stocks Lagging Biodesix (BDSX) This Year? - Yahoo Finance
HC Wainwright Initiates Biodesix at Buy With $26 Price Target - marketscreener.com
H.C. Wainwright Initiates Biodesix(BDSX.US) With Buy Rating, Announces Target Price $26 - Moomoo
Biodesix, Inc. (BDSX) reports Q1 loss, tops revenue estimates - MSN
BDSX Q1 2026 Earnings: EPS Beat on Lower-Than-Expected Loss; Stock Dips SlightlyLow Growth Earnings - newsline.com
BDSX Q1 2026 Earnings: EPS Surpasses Estimates Despite Net Loss, Stock Ticks DownEarnings Turnaround - newsline.com
Biodesix (BDSX) Tests Resistance After Modest Gain Amid Sector VolatilityVWAP Deviation - newsline.com
Biodesix Inc. (BDSX) Shows Resilience: Shares Gain 2.08% Amid Sector InterestAccumulation Line - newsline.com
Zacks Industry Outlook Highlights BrightSpring Health Services, Biodesix and HealthEquity - sharewise.com
Biodesix Inc Stock (BDSX) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):